Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Determining whether real estate or stocks are better for your investments requires careful analysis. Weigh the advantages of each option.
26,575 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
NVIDIA riding robust AI demand, elevated data-center spending, and resilient margins as 2026 unfolds. Analysts weigh ...
Oil traders are weighing a hypothetical '$200 trump radar' scenario as prices approach extreme levels. This report ex...
Cathie Wood’s flagship fund is missing out on a tech-fueled bull run, lagging the AI-driven rally as investors rotate...
FXU climbs 17% over the past year as data centers reshape power demand, renewing growth for utilities and attracting ...
Investors are buzzing about a possible SpaceX-Tesla merger. This guide explains the real possibilities, benefits, ris...
New estimates place the true national debt per U.S. household near $1 million when counting unfunded promises. Offici...
May construction starts fell to a six-year low, tightening supply and heightening buying pressure for home buyers as ...
A space-focused Nasdaq-100 entrant is drawing attention after earnings and a key index promotion. Investors see a pot...
Ukraine’s drone attacks more have targeted Russia’s energy complex, causing refinery fires and fuel shortages that ec...
A new push from across the political spectrum asks whether the public should share in AI profits. This article breaks...
What if a $1,000 bet on COSTCO in 2006 rode all the way to today? This article breaks down the math, compares it to t...